Countdown to Viatris (VTRS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Werte in diesem Artikel
Wall Street analysts forecast that Viatris (VTRS) will report quarterly earnings of $0.63 per share in its upcoming release, pointing to a year-over-year decline of 16%. It is anticipated that revenues will amount to $3.65 billion, exhibiting a decrease of 2.8% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 3.8% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.Bearing this in mind, let's now explore the average estimates of specific Viatris metrics that are commonly monitored and projected by Wall Street analysts.Analysts forecast 'Revenues- Total Net Sales' to reach $3.64 billion. The estimate points to a change of -2.7% from the year-ago quarter.According to the collective judgment of analysts, 'Net Sales- Developed Markets' should come in at $2.20 billion. The estimate points to a change of -4.1% from the year-ago quarter.The collective assessment of analysts points to an estimated 'Net Sales- Emerging Markets' of $549.78 million. The estimate indicates a year-over-year change of +3.1%.Analysts expect 'Net Sales- JANZ' to come in at $302.56 million. The estimate points to a change of -12.1% from the year-ago quarter.The average prediction of analysts places 'Net Sales- Greater China' at $578.59 million. The estimate indicates a year-over-year change of +3%.The consensus estimate for 'Revenues- Other revenues' stands at $11.40 million. The estimate indicates a change of -13.6% from the prior-year quarter.The combined assessment of analysts suggests that 'Net Sales- Emerging Markets- Generics' will likely reach $140.08 million. The estimate indicates a change of +2% from the prior-year quarter.Based on the collective assessment of analysts, 'Net Sales- Emerging Markets- Brands' should arrive at $409.75 million. The estimate points to a change of +3.5% from the year-ago quarter.It is projected by analysts that the 'Net Sales- JANZ- Generics' will reach $148.58 million. The estimate suggests a change of -4.2% year over year.Analysts' assessment points toward 'Net Sales- JANZ- Brands' reaching $148.32 million. The estimate suggests a change of -21.7% year over year.The consensus among analysts is that 'Net Sales- Developed Markets- Brands' will reach $1.22 billion. The estimate indicates a year-over-year change of -0.1%.Analysts predict that the 'Net Sales- Developed Markets- Generics' will reach $1.02 billion. The estimate suggests a change of -5.5% year over year. View all Key Company Metrics for Viatris here>>> Viatris shares have witnessed a change of +3.5% in the past month, in contrast to the Zacks S&P 500 composite's +1% move. With a Zacks Rank #2 (Buy), VTRS is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viatris Inc. (VTRS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Viatris und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Viatris
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Viatris
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Viatris Inc Registered Shs
Analysen zu Viatris Inc Registered Shs
Keine Analysen gefunden.